US EditionPublished • loading... • Updated
Curis to Present at Upcoming 30th Annual SNO Meeting
Summary by The Chandler Arizonan
8 Articles
8 Articles
The Chandler Arizonan+7 Reposted by 7 other sources
Curis to Present at Upcoming 30th Annual SNO Meeting
LEXINGTON, Mass., Nov. 14, 2025 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 inhibitor, today announced that Curis will report emavusertib and BTKi clinical data in…
·Chandler, United States
Read Full ArticleCoverage Details
Total News Sources8
Leaning Left1Leaning Right0Center3Last UpdatedBias Distribution75% Center
Bias Distribution
- 75% of the sources are Center
75% Center
L 25%
C 75%
Factuality
To view factuality data please Upgrade to Premium
